SNC
PJP icon

Stifel Nicolaus & Co’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Stifel Nicolaus & Co’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$2.28M Buy
49,438
+4,965
+11% +$227K 0.04% 426
2013
Q2 		$1.88M Buy
+44,473
New +$1.85M 0.03% 455

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PFG
Pacific Financial Group Bellevue, Washington $186M AUM 16.59% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Stifel Nicolaus & Co's PJP Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Invesco Pharmaceuticals ETF (PJP) stake by 11% in Q3 2013, buying an estimated $227K and bringing the position to 49,438 shares worth $2.28M. The position accounts for 0.04% of the portfolio, ranked #426.

Stifel Nicolaus & Co first reported a position in PJP in Q2 2013 and has held it in 2 quarters since. 69 funds tracked by Wall St. Rank hold PJP as of Q3 2013.

  • Stifel Nicolaus & Co held 49,438 shares of Invesco Pharmaceuticals ETF worth $2.28M as of Q3 2013.
  • Stifel Nicolaus & Co bought 4,965 Invesco Pharmaceuticals ETF shares in Q3 2013, an estimated $227K.
  • Invesco Pharmaceuticals ETF made up 0.04% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #426 holding.
  • Stifel Nicolaus & Co first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 2 quarters since.
  • 69 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.